Inactivating mutations of Patched-1 (PTCH1) are the most common (30–60%) in sporadic BCC [8]–[11], followed by mutations (10–20%) in Smoothened (SMO) or Suppressor of Fused (SU(FU)) [11]–[16]. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.